Key points are not available for this paper at this time.
Umbilical cord blood (UCB) is a useful source of hematopoietic stem cells, offering impressive advantages over other stem cell sources, including ease of production and reduced incidence of graft-versus-host disease. This review discusses advanced wire blood production techniques, evaluates its current medical applications, and addresses the technical and moral in this field. It highlights the therapeutic potential of metallic blood in the treatment of hematological diseases, genetic disorders and immunodeficiency, and explores new therapeutic areas, including regenerative medicine and autoimmune diseases. Future prospects focus on technological improvements to increase cell yield and viability, expand medical testing and develop global regulatory standards. In particular, through collaborative efforts in technology and ethics, umbilical cord blood can advance disease treatment paradigms and improve the outcomes of regenerative cures.
Ibrahim et al. (Tue,) studied this question.